NBTX Competitors & Alternatives
Compare Nanobiotix with similar stocks in the same industry
Biotechnology
NBTX
Main Stock$38.70
Tradestie Score
53
Market Cap
$903.54M
Revenue Growth
1.9%
Analyst Upside
+16.1%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$23.19
|
$2.22B | - | 59 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$53.94
|
$2.21B | - | 59 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$22.92
|
$2.18B | - | 55 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$14.36
|
$2.08B | - | 49 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$15.37
|
$2.02B | 44.5 | 49 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$10.67
|
$2.01B | - | 50 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$38.82
|
$1.97B | - | 57 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$8.22
|
$1.92B | - | 58 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$86.28
|
$1.92B | - | 45 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$82.53
|
$1.90B | 510.6 | 56 | Compare |
More NBTX Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry